Primary endoscopic nasopharyngectomy for nasopharyngeal carcinoma: systematic review & meta-analysis - Scorecard - MDSpire

Primary endoscopic nasopharyngectomy for nasopharyngeal carcinoma: systematic review & meta-analysis

  • By

  • Siyuan Ding

  • Leo Li

  • Jenny Lee

  • Brian Mak

  • Christopher Liao

  • Andy Chan

  • Levina Li

  • Calvin Lai

  • Samuel Chow

  • Jason Chan

  • David Yeung

  • June 26, 2026

  • 0 min

Share

Clinical Scorecard: Systematic Review and Meta-Analysis of Primary Endoscopic Nasopharyngectomy in Treating Nasopharyngeal Carcinoma

At a Glance

CategoryDetail
ConditionNasopharyngeal Carcinoma
Key MechanismsPrimary endoscopic nasopharyngectomy (pENPG) aims to reduce radiotherapy-associated toxicities while providing surgical intervention.
Target PopulationPatients diagnosed with primary nasopharyngeal carcinoma (pNPC), particularly those with localized stage I disease.
Care SettingClinical evaluation of surgical interventions for nasopharyngeal carcinoma.

Key Highlights

  • Meta-analysis showed a pooled 5-year overall survival (OS) of 90.6% for pENPG.
  • 100% 5-year OS reported for stage I NPC treated with pENPG in two studies.
  • pENPG may reduce radiotherapy-associated toxicities compared to intensity-modulated radiotherapy (IMRT).
  • Surgical complications severity correlates with the extent of resection.
  • pENPG utilization is rare in current practice.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of NPC should be based on WHO classification.

Management

  • Consider pENPG as an alternative to IMRT for early-stage NPC to minimize toxicities.

Monitoring & Follow-up

  • Follow-up and survival outcomes should be documented post-surgery.

Risks

  • Radiotherapy can lead to significant late toxicities including dysphagia, hearing loss, and necrosis.

Patient & Prescribing Data

Patients with localized stage I nasopharyngeal carcinoma.

pENPG may be a feasible option for patients to avoid the toxicities associated with radiotherapy.

Clinical Best Practices

  • Evaluate selection criteria for pENPG based on tumor stage and patient health.
  • Utilize a multidisciplinary approach for treatment planning in NPC.
  • Conduct prospective studies to further evaluate the efficacy and safety of pENPG.

Related Resources & Content

Original Source(s)

Related Content